Company announcements · 20/10/2026

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on October 20, 2026 under the Company's 2026 Employment Inducement Incentiv…